FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charles Boone

Research Profile

Chemicals & Drugs

Procedures

Disorders

Activities & Behaviors

Living Beings

Concepts & Ideas

Precancerous Conditions

Physiology

Cell Divisions

Objects

Co-author Network

Publications

TOP 3
Konstantin Christov-Tzelkov; Richard C Moon; Daniel D Lantvit; Charles W Boone; Gary J Kelloff; Vernon E Steele; Ronald A Lubet; John M Pezzuto
Prostate intraepithelial neoplasia in Noble rats, a potential intermediate endpoint for chemoprevention studies.
Vernon E Steele; Charles W Boone; Daniel Dauzonne; Chinthalapally V Rao; René V Bensasson
Correlation between electron-donating ability of a series of 3-nitroflavones and their efficacy to inhibit the onset and progression of aberrant crypt foci in the rat colon.
Konstantin Christov-Tzelkov; Richard C Moon; Daniel D Lantvit; Charles W Boone; Vernon E Steele; Ronald A Lubet; Gary J Kelloff; John M Pezzuto
9-cis-retinoic acid but not 4-(hydroxyphenyl)retinamide inhibits prostate intraepithelial neoplasia in Noble rats.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charles Boone (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Konstantin Christov-Tzelkov; Richard C Moon; Daniel D Lantvit; Charles W Boone; Gary J Kelloff; Vernon E Steele; Ronald A Lubet; John M Pezzuto
Prostate intraepithelial neoplasia in Noble rats, a potential intermediate endpoint for chemoprevention studies.
European journal of cancer (Oxford, England : 1990) 2004;40(9):1404-11.
2002: Vernon E Steele; Charles W Boone; Daniel Dauzonne; Chinthalapally V Rao; René V Bensasson
Correlation between electron-donating ability of a series of 3-nitroflavones and their efficacy to inhibit the onset and progression of aberrant crypt foci in the rat colon.
Cancer research 2002;62(22):6506-9.
2002: Konstantin Christov-Tzelkov; Richard C Moon; Daniel D Lantvit; Charles W Boone; Vernon E Steele; Ronald A Lubet; Gary J Kelloff; John M Pezzuto
9-cis-retinoic acid but not 4-(hydroxyphenyl)retinamide inhibits prostate intraepithelial neoplasia in Noble rats.
Cancer research 2002;62(18):5178-82.
2001: Charles W Boone; Ronald Lieberman; T Mairinger; B Palcic; James Bacus; P Bartels
Computer-assisted image analysis-derived intermediate endpoints.
Urology 2001;57(4 Suppl 1):129-31.
2001: Gary J Kelloff; Ronald Lieberman; Vernon E Steele; Charles W Boone; Ronald A Lubet; Levy Kopelovich; WA Malone; James A Crowell; H R Higley; Caroline C Sigman
Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer.
Urology 2001;57(4 Suppl 1):46-51.
2000: Charles W Boone; Gary D Stoner; James Bacus; Valeriy Kagan; Mark A Morse; Gary J Kelloff; James Bacus
Chemoprevention with theaflavins of rat esophageal intraepithelial neoplasia quantitatively monitored by image tile analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(11):1149-54.
2000: Charles W Boone; Gary D Stoner; James Bacus; Valeriy Kagan; Mark A Morse; Gary J Kelloff; James Bacus
Quantitative grading of rat esophageal carcinogenesis using computer-assisted image tile analysis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(5):495-500.
2000: Gary J Kelloff; James A Crowell; Vernon E Steele; Ronald A Lubet; WA Malone; Charles W Boone; Levy Kopelovich; Ernest T Hawk; Ronald Lieberman; JA Lawrence; I Ali; Jaye L Viner; Caroline C Sigman
Progress in cancer chemoprevention: development of diet-derived chemopreventive agents.
The Journal of nutrition 2000;130(2S Suppl):467S-471S.
2000: Gary J Kelloff; Caroline C Sigman; K M Johnson; Charles W Boone; Peter Greenwald; James A Crowell; Ernest T Hawk; L A Doody
Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(2):127-37.
2000: Charles W Boone; Gary J Kelloff
Endpoint markers for cancer chemoprevention trials derived from the lesion of precancer (intraepithelial neoplasia) measured by computer-assisted quantitative image analysis.
Journal of cellular biochemistry. Supplement 2000;34():67-72.
2000: Vernon E Steele; Gary J Kelloff; DA Balentine; Charles W Boone; Rajendra Mehta; D Bagheri; Caroline C Sigman; S Zhu; Sheela Sharma
Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays.
Carcinogenesis 2000;21(1):63-7.
1999: James Bacus; Charles W Boone; James Bacus; M Follen; Gary J Kelloff; Valeriy Kagan; S M Lippman
Image morphometric nuclear grading of intraepithelial neoplastic lesions with applications to cancer chemoprevention trials.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1999;8(12):1087-94.
1999: Charles W Boone
Can breast cancer be prevented?
Annals of Saudi medicine 1999;19(3):276.
1999: Vernon E Steele; D Bagheri; DA Balentine; Charles W Boone; Rajendra Mehta; Mark A Morse; Sheela Sharma; Caroline C Sigman; Gary D Stoner; Michael J Wargovich; John H Weisburger; S Zhu; Gary J Kelloff
Preclinical efficacy studies of green and black tea extracts.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1999;220(4):210-2.
1999: Gary J Kelloff; James A Crowell; Vernon E Steele; Ronald A Lubet; Charles W Boone; WA Malone; Ernest T Hawk; Ronald Lieberman; JA Lawrence; Levy Kopelovich; I Ali; Jaye L Viner; Caroline C Sigman
Progress in cancer chemoprevention.
Annals of the New York Academy of Sciences 1999;889():1-13.
1999: Gary J Kelloff; Ronald Lieberman; Vernon E Steele; Charles W Boone; Ronald A Lubet; L Kopelovitch; WA Malone; James A Crowell; Caroline C Sigman
Chemoprevention of prostate cancer: concepts and strategies.
European urology 1999;35(5-6):342-50.
1998: Vernon E Steele; Charles W Boone; Ronald A Lubet; James A Crowell; CA Holmes; Caroline C Sigman; Gary J Kelloff
Preclinical drug development paradigms for chemopreventives.
Hematology/oncology clinics of North America 1998;12(5):943-61, v-vi.
1998: R Parshad; KK Sanford; FM Price; Vernon E Steele; Robert E Tarone; Gary J Kelloff; Charles W Boone
Protective action of plant polyphenols on radiation-induced chromatid breaks in cultured human cells.
Anticancer research 1998;18(5A):3263-6.
1998: Charles W Boone; Vernon E Steele; D Gaylor; Gary J Kelloff
Use of Druckrey analysis to quantitatively evaluate the chemopreventive efficacy of N-difluoromethylornithine (DFMO), a prototype proliferation inhibitor.
Mutation research 1998;402(1-2):173-7.
1998: R Lieberman; James A Crowell; Ernest T Hawk; Charles W Boone; Caroline C Sigman; Gary J Kelloff
Development of new cancer chemoprevention agents: role of pharmacokinetic/pharmacodynamic and intermediate endpoint biomarker monitoring.
Clinical chemistry 1998;44(2):420-7.
1998: Charles W Boone; G J Kelloff
Endpoint markers for clinical trials of chemopreventive agents derived from the properties of epithelial precancer (intraepithelial neoplasia) measured by computer-assisted image analysis.
Cancer surveys 1998;32():133-47.
1998: Gary J Kelloff; Ronald A Lubet; Ronald Lieberman; K Eisenhauer; Vernon E Steele; James A Crowell; Ernest T Hawk; Charles W Boone; Caroline C Sigman
Aromatase inhibitors as potential cancer chemopreventives.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1998;7(1):65-78.
1998: John H Weisburger; Abraham Rivenson; Cesar Aliaga; Joel Reinhardt; Gary J Kelloff; Charles W Boone; Vernon E Steele; DA Balentine; Brian Pittman; Edith Zang
Effect of tea extracts, polyphenols, and epigallocatechin gallate on azoxymethane-induced colon cancer.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1998;217(1):104-8.
1997: Charles W Boone; James Bacus; James Bacus; Vernon E Steele; Gary J Kelloff
Properties of intraepithelial neoplasia relevant to cancer chemoprevention and to the development of surrogate end points for clinical trials.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1997;216(2):151-65.
1997: G J Kelloff; Ernest T Hawk; Judith E Karp; James A Crowell; Charles W Boone; V E Steele; R A Lubet; Caroline C Sigman
Progress in clinical chemoprevention.
Seminars in oncology 1997;24(2):241-52.
1997: Gary J Kelloff; Ronald A Lubet; Judith R Fay; Vernon E Steele; Charles W Boone; James A Crowell; Caroline C Sigman
Farnesyl protein transferase inhibitors as potential cancer chemopreventives.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(4):267-82.
1997: James Bacus; James Bacus; G D Stoner; Richard C Moon; Gary J Kelloff; Charles W Boone
Quantitation of preinvasive neoplastic progression in animal models of chemical carcinogenesis.
Journal of cellular biochemistry. Supplement 1997;28-29():21-38.
1997: Charles W Boone; James Bacus; James Bacus; Vernon E Steele; Gary J Kelloff
Properties of intraepithelial neoplasia relevant to the development of cancer chemopreventive agents.
Journal of cellular biochemistry. Supplement 1997;28-29():1-20.
1997: Mark A Morse; Laura Kresty; Vernon E Steele; Gary J Kelloff; Charles W Boone; DA Balentine; ME Harbowy; Gary D Stoner
Effects of theaflavins on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis.
Nutrition and cancer 1997;29(1):7-12.
1997: Charles W Boone; Gary J Kelloff
Biomarker end-points in cancer chemoprevention trials.
IARC scientific publications 1997;(142):273-80.
1997: Gary J Kelloff; Charles W Boone; James A Crowell; S G Nayfield; Ernest T Hawk; Vernon E Steele; Ronald A Lubet; Caroline C Sigman
Perspectives and progress in development of breast cancer chemopreventive drugs.
Progress in clinical and biological research 1997;396():159-83.
1996: Gary J Kelloff; Ernest T Hawk; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Caroline C Sigman
Perspectives on chemoprevention agent selection and short-term clinical prevention trials.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 1996;5 Suppl 2():79-85.
1996: Gary J Kelloff; Ernest T Hawk; James A Crowell; Charles W Boone; S G Nayfield; M Perloff; V E Steele; Ronald A Lubet
Strategies for identification and clinical evaluation of promising chemopreventive agents.
Oncology (Williston Park, N.Y.) 1996;10(10):1471-84; discussion 1484-8.
1996: Gary J Kelloff; J R Fay; V E Steele; Ronald A Lubet; Charles W Boone; James A Crowell; Caroline C Sigman
Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1996;5(8):657-66.
1996: Gary J Kelloff; James A Crowell; Ernest T Hawk; V E Steele; Ronald A Lubet; Charles W Boone; J M Covey; L A Doody; Gilbert S Omenn; Peter Greenwald; Waun Ki Hong; D R Parkinson; D Bagheri; G T Baxter; M Blunden; M K Doeltz; K M Eisenhauer; K Johnson; G G Knapp; D G Longfellow; W F Malone; S G Nayfield; H E Seifried; L M Swall; Caroline C Sigman
Strategy and planning for chemopreventive drug development: clinical development plans II.
Journal of cellular biochemistry. Supplement 1996;26():54-71.
1996: Gary J Kelloff; Charles W Boone; James A Crowell; V E Steele; Ronald A Lubet; L A Doody; W F Malone; Ernest T Hawk; Caroline C Sigman
New agents for cancer chemoprevention.
Journal of cellular biochemistry. Supplement 1996;26():1-28.
1996: Gary J Kelloff; Charles W Boone; James A Crowell; S G Nayfield; Ernest T Hawk; W F Malone; V E Steele; Ronald A Lubet; Caroline C Sigman
Risk biomarkers and current strategies for cancer chemoprevention.
Journal of cellular biochemistry. Supplement 1996;25():1-14.
1996: Gary J Kelloff; Charles W Boone; V E Steele; James A Crowell; Ronald A Lubet; Peter Greenwald; Ernest T Hawk; J R Fay; Caroline C Sigman
Mechanistic considerations in the evaluation of chemopreventive data.
IARC scientific publications 1996;(139):203-19.
1995: Peter Greenwald; Gary J Kelloff; Charles W Boone; S S McDonald
Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1995;4(7):691-702.
1995: Gary J Kelloff; Charles W Boone; James A Crowell; S G Nayfield; Ernest T Hawk; V E Steele; Ronald A Lubet; Caroline C Sigman
Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary.
Journal of cellular biochemistry. Supplement 1995;23():1-9.
1995: Gary J Kelloff; J R Johnson; James A Crowell; Charles W Boone; J J DeGeorge; V E Steele; M U Mehta; J W Temeck; W J Schmidt; G Burke
Approaches to the development and marketing approval of drugs that prevent cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1995;4(1):1-10.
1994: Charles W Boone; L W Wattenberg
Current strategies of cancer chemoprevention: 13th Sapporo cancer seminar.
Cancer research 1994;54(12):3315-8.
1994: Gary J Kelloff; Charles W Boone; V E Steele; James A Crowell; Ronald A Lubet; Caroline C Sigman
Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
Cancer research 1994;54(7 Suppl):2015s-2024s.
1994: James A Crowell; E I Goldenthal; Gary J Kelloff; W F Malone; Charles W Boone
Chronic toxicity studies of the potential cancer preventive 2-(difluoromethyl)-dl-ornithine.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1994;22(3):341-54.
1994: Gary J Kelloff; Charles W Boone; James A Crowell; V E Steele; Ronald A Lubet; Caroline C Sigman
Chemopreventive drug development: perspectives and progress.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1994;3(1):85-98.
1994: Charles W Boone; Gary J Kelloff
Development of surrogate endpoint biomarkers for clinical trials of cancer chemopreventive agents: relationships to fundamental properties of preinvasive (intraepithelial) neoplasia.
Journal of cellular biochemistry. Supplement 1994;19():10-22.
1994: Gary J Kelloff; Charles W Boone; James A Crowell; V E Steele; Ronald A Lubet; L A Doody
Surrogate endpoint biomarkers for phase II cancer chemoprevention trials.
Journal of cellular biochemistry. Supplement 1994;19():1-9.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: calcium.
Journal of cellular biochemistry. Supplement 1994;20():86-109.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: aspirin.
Journal of cellular biochemistry. Supplement 1994;20():74-85.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: N-Acetyl-l-cysteine.
Journal of cellular biochemistry. Supplement 1994;20():63-73.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Strategy and planning for chemopreventive drug development: clinical development plans. Chemoprevention Branch and Agent Development Committee. National Cancer Institute.
Journal of cellular biochemistry. Supplement 1994;20():55-62.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: vitamin E.
Journal of cellular biochemistry. Supplement 1994;20():282-99.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: vitamin D3 and analogs.
Journal of cellular biochemistry. Supplement 1994;20():268-81.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: tamoxifen.
Journal of cellular biochemistry. Supplement 1994;20():252-67.
1994: Gary J Kelloff; J R Johnson; James A Crowell; Charles W Boone; J J DeGeorge; V E Steele; M U Mehta; J W Temeck; W J Schmidt; G Burke
Guidance for development of chemopreventive agents.
Journal of cellular biochemistry. Supplement 1994;20():25-31.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: sulindac.
Journal of cellular biochemistry. Supplement 1994;20():240-51.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: Proscar.
Journal of cellular biochemistry. Supplement 1994;20():231-9.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: piroxicam.
Journal of cellular biochemistry. Supplement 1994;20():219-30.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: oltipraz.
Journal of cellular biochemistry. Supplement 1994;20():205-18.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: ibuprofen.
Journal of cellular biochemistry. Supplement 1994;20():197-204.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: N-(4-hydroxyphenyl)retinamide.
Journal of cellular biochemistry. Supplement 1994;20():176-96.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: 18beta-glycyrrhetinic acid.
Journal of cellular biochemistry. Supplement 1994;20():166-75.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: 2-difluoromethylornithine (DFMO).
Journal of cellular biochemistry. Supplement 1994;20():147-65.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: DHEA analog 8354.
Journal of cellular biochemistry. Supplement 1994;20():141-6.
1994: Gary J Kelloff; James A Crowell; Charles W Boone; V E Steele; Ronald A Lubet; Peter Greenwald; D S Alberts; J M Covey; L A Doody; G G Knapp
Clinical development plan: beta-carotene and other carotenoids.
Journal of cellular biochemistry. Supplement 1994;20():110-140.
1994: Gary J Kelloff; Charles W Boone; V E Steele; J R Fay; Ronald A Lubet; James A Crowell; Caroline C Sigman
Mechanistic considerations in chemopreventive drug development.
Journal of cellular biochemistry. Supplement 1994;20():1-24.
1993: Charles W Boone; Gary J Kelloff
Intraepithelial neoplasia, surrogate endpoint biomarkers, and cancer chemoprevention.
Journal of cellular biochemistry. Supplement 1993;17F():37-48.
1993: Gary J Kelloff; Charles W Boone; V K Steele; M Perloff; J Crowell; L A Doody
Development of chemopreventive agents for lung and upper aerodigestive tract cancers.
Journal of cellular biochemistry. Supplement 1993;17F():2-17.
1993: Charles W Boone; Gary J Kelloff; V E Steele
Histopathology of human intraepithelial neoplasia with implications for chemoprevention strategy.
Basic life sciences 1993;61():291-300.
1993: Gary J Kelloff; Charles W Boone; V E Steele; James A Crowell; Ronald A Lubet; L A Doody; Peter Greenwald
Development of breast cancer chemopreventive drugs.
Journal of cellular biochemistry. Supplement 1993;17G():2-13.
1993: Charles W Boone; Gary J Kelloff; L S Freedman
Intraepithelial and postinvasive neoplasia as a stochastic continuum of clonal evolution, and its relationship to mechanisms of chemopreventive drug action.
Journal of cellular biochemistry. Supplement 1993;17G():14-25.
1992: Gary J Kelloff; Charles W Boone; W F Malone; V E Steele
Chemoprevention clinical trials.
Mutation research 1992;267(2):291-5.
1992: Charles W Boone; V E Steele; Gary J Kelloff
Screening for chemopreventive (anticarcinogenic) compounds in rodents.
Mutation research 1992;267(2):251-5.
1992: Charles W Boone; Gary J Kelloff; V E Steele
Natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy.
Cancer research 1992;52(7):1651-9.
1992: Charles W Boone; Gary J Kelloff; V E Steele
The natural history of intraepithelial neoplasia: relevance to the search for intermediate endpoint biomarkers.
Journal of cellular biochemistry. Supplement 1992;16G():23-6.
1992: Gary J Kelloff; W F Malone; Charles W Boone; V E Steele; L A Doody
Intermediate biomarkers of precancer and their application in chemoprevention.
Journal of cellular biochemistry. Supplement 1992;16G():15-21.
1992: Gary J Kelloff; Charles W Boone; W F Malone; V E Steele; L A Doody
Development of chemopreventive agents for bladder cancer.
Journal of cellular biochemistry. Supplement 1992;16I():1-12.
1992: Gary J Kelloff; Charles W Boone; W F Malone; V E Steele; L A Doody
Introductory remarks: development of chemopreventive agents for prostate cancer.
Journal of cellular biochemistry. Supplement 1992;16H():1-8.
1990: Gary J Kelloff; W F Malone; Charles W Boone; Caroline C Sigman; J R Fay
Progress in applied chemoprevention research.
Seminars in oncology 1990;17(4):438-55.
1990: Charles W Boone; Gary J Kelloff; W E Malone
Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review.
Cancer research 1990;50(1):2-9.